Cytosorbents Corporation (CTSO) vs IRIDEX Corporation (IRIX)
- Cytosorbents Corporation CTSO 4.58 +4.09%
- IRIDEX Corporation IRIX 0.73 +1.39%
Cytosorbents Corporation and IRIDEX Corporation are both Medical Devices companies. Cytosorbents Corporation and IRIDEX Corporation are of similar size ($13.9M and $12.7M). IRIDEX Corporation grew revenue faster over the last twelve months: 3.68% against 3.07%. IRIDEX Corporation has the higher net margin (−6.88% vs −48.9%) and the higher return on invested capital (−63.1% vs −66.9%). Across the 17 metrics below, IRIDEX Corporation leads on 13 and Cytosorbents Corporation on 4.
Valuation
Profitability
| Metric | CTSO | IRIX | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.61% | 35.92% | 57.16% |
| Operating margin | (34.74%) | (5.39%) | (18.70%) |
| Net margin | (48.94%) | (6.88%) | (19.62%) |
| Free cash flow margin | (25.32%) | (3.88%) | (7.24%) |
| Return on equity | (336.17%) | 308.17% | (13.14%) |
| Return on assets | (42.38%) | (12.06%) | (19.72%) |
| Return on invested capital | (66.90%) | (63.07%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack